Hajizadeh Nastaran, Baghestani Ahmad Reza, Pourhoseingholi Mohamad Amin, Najafimehr Hadis, Fazeli Zeinab, Bosani Luca
Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S54-S61.
The aim of this study was to obtain more accurate estimates of the liver cancer incidence rate after correcting for misclassification error in cancer registry across Iranian provinces.
Nowadays having a thorough knowledge of geographic distribution of disease incidence has become essential for identifying the influential factors on cancer incidence.
Data of liver cancer incidence was extracted from Iranian annual of national cancer registration report 2008. Expected coverage of cancer cases for each province was calculated. Patients of each province that had covered fewer cancer cases than 100% of its expectation, were supposed to be registered at an adjacent province which had observed more cancer cases than 100% of its expected coverage. For estimating the rate of misclassification in registering cancer incidence, a Bayesian method was implemented. Beta distribution was considered for misclassified parameter since its expectation converges to the misclassification rate. Parameters of beta distribution were selected based on the expected coverage of cancer cases in each province. After obtaining the misclassification rate, the incidence rates were re-estimated.
There was misclassification error in registering new cancer cases across the provinces of Iran. Provinces with more medical facilities such as Tehran which is the capital of the country, Mazandaran in north of the Iran, East Azerbaijan in north-west, Razavi Khorasan in north-east, Isfahan in central part, and Fars and Khozestan in south of Iran had significantly higher rates of liver cancer than their neighboring provinces. On the other hand, their neighboring provinces with low medical facilities such as Ardebil, West Azerbaijan, Golestan, South and north Khorasans, Qazvin, Markazi, Arak, Sistan & balouchestan, Kigilouye & boyerahmad, Bushehr, Ilam and Hormozgan, had observed fewer cancer cases than their expectation.
Accounting and correcting the regional misclassification are necessary for identifying high risk areas of the country and effective policy making to cope with cancer.
本研究的目的是在纠正伊朗各省份癌症登记中的错误分类误差后,获得更准确的肝癌发病率估计值。
如今,全面了解疾病发病率的地理分布对于确定影响癌症发病率的因素至关重要。
从《2008年伊朗国家癌症登记年度报告》中提取肝癌发病率数据。计算每个省份癌症病例的预期覆盖范围。每个省份中癌症病例覆盖少于其预期100%的患者,假定登记在相邻省份,该相邻省份观察到的癌症病例多于其预期覆盖的100%。为估计癌症发病率登记中的错误分类率,采用了贝叶斯方法。由于其期望值收敛于错误分类率,因此对错误分类参数考虑贝塔分布。基于每个省份癌症病例的预期覆盖范围选择贝塔分布的参数。获得错误分类率后,重新估计发病率。
伊朗各省份在登记新癌症病例时存在错误分类误差。拥有更多医疗设施的省份,如伊朗首都德黑兰、伊朗北部的马赞德兰、西北部的东阿塞拜疆、东北部的拉扎维霍拉桑、中部的伊斯法罕以及伊朗南部的法尔斯和胡齐斯坦,其肝癌发病率明显高于其邻近省份。另一方面,其医疗设施较少的邻近省份,如阿尔达比勒、西阿塞拜疆、戈勒斯坦、南霍拉桑和北霍拉桑、加兹温、马尔卡齐、阿拉克、锡斯坦-俾路支斯坦、基吉卢耶-博耶拉赫马德、布什尔、伊拉姆和霍尔木兹甘,观察到的癌症病例少于预期。
核算和纠正区域错误分类对于确定该国的高风险地区以及制定有效的癌症应对政策是必要的。